This was a 5-week , randomized , placebo-controlled , double-blind , crossover trial of clarithromycin 500mg with breakfast and lunch , in patients with hypersomnolence syndromes ( excluding narcolepsy with cataplexy ) and evidence for abnormal cerebrospinal fluid potentiation of GABA-A receptors .